Sodexo (SW) Guidance summary
Event summary combining transcript, slides, and related documents.
Guidance summary
26 Dec, 2025Opening remarks and agenda
Call convened to update on H1 2025 estimates and full-year guidance, with Q&A to follow.
Management limited comments to press release disclosures, with full audited results to be published April 4.
Chairwoman and CEO Sophie Bellon highlighted strong industry fundamentals but noted underperformance in North America, especially in Education and Healthcare, impacting initial expectations.
Guidance on key objectives
Full-year organic revenue growth guidance revised to 3%-4%, down from 5.5%-6.5%, with 10-20 basis points UOP margin improvement, reduced from 30-40 bps.
H2 organic growth expected between 2.5% and 4.5%.
Retention rate targeted at 94%-94.5%, including the impact of a lost global contract, with no revenue effect until H2 2026; client retention at 93.9% over the last 12 months.
Adjustments driven by weaker volume trends in North America Education and delayed Healthcare contract ramp-ups.
Robust cash flow reported for H1, with more details to come in April.
Market trends and strategic opportunities
Growth strong in Europe, healthcare, seniors, Australia, India, and Brazil; North America faced challenges, especially in education and healthcare.
North America organic growth at 3.5%, below expectations due to soft Education volumes and Healthcare delays; Business & Administrations and Sodexo Live! showed good growth.
Europe saw 2.1% organic growth, with strong Healthcare & Seniors performance but soft Facilities Management.
Rest of the World delivered 6.6% organic growth, led by Australia, India, and Brazil.
Development rate strong, with over €1 billion in global sales in H1, a record volume.
Latest events from Sodexo
- H1 growth and margin gains, but full-year outlook trimmed on North America softness.SW
H1 202511 Feb 2026 - Q1 revenue up 1.9% to €6.4B; organic growth 4.6%; guidance and strong pipeline reaffirmed.SW
Q1 2025 TU3 Feb 2026 - Strong growth, strategic transformation, and all resolutions passed with robust shareholder support.SW
AGM 20243 Feb 2026 - Q3 organic growth reached 6.8%, with FY24 guidance at the top of the 6–8% range.SW
Q3 20243 Feb 2026 - Strong FY24 growth, margin gains, and cash flow; FY25 outlook remains positive.SW
H2 202419 Jan 2026 - Q1 revenue grew 1.8% organically to €6.3B, with guidance for FY26 reaffirmed despite currency headwinds.SW
Q1 2026 TU8 Jan 2026 - Q3 organic revenue growth reached 3.0%, led by strong Rest of World performance.SW
Q3 2025 TU14 Nov 2025 - FY25 delivered 3.3% growth and margin gains; FY26 to see slower growth and margin pressure.SW
H2 202523 Oct 2025 - Thierry Delaporte appointed CEO to drive growth, transformation, and governance evolution.SW
Status Update9 Oct 2025